<!doctype html><html class=no-js lang=en><head><meta charset=UTF-8><meta name=viewport content="width=device-width,initial-scale=1"><title>ç§‘ç ”æ—¥æŠ¥ 2025-12-09 - ç”Ÿä¿¡æ™®æ‹‰æ–¯</title>
<script>(function(e,t){e[t]=e[t].replace("no-js","js")})(document.documentElement,"className")</script><meta name=description content><meta property="og:url" content="https://ixxmu.github.io/posts/dailyreports/2025-12-09/"><meta property="og:site_name" content="ç”Ÿä¿¡æ™®æ‹‰æ–¯"><meta property="og:title" content="ç§‘ç ”æ—¥æŠ¥ 2025-12-09"><meta property="og:description" content="ğŸ“… Daily Report - 2025-12-09 ä»Šæ—¥ç­›é€‰å‡º 23 æ¡å†…å®¹ï¼Œæ¥è‡ª 1 ä¸ªæ¥æº"><meta property="og:locale" content="zh_cn"><meta property="og:type" content="article"><meta property="article:section" content="posts"><meta property="article:published_time" content="2025-12-09T00:00:00+00:00"><meta property="article:modified_time" content="2025-12-09T00:00:00+00:00"><meta property="article:tag" content="Research"><meta property="article:tag" content="Daily"><meta property="article:tag" content="Week502025"><meta itemprop=name content="ç§‘ç ”æ—¥æŠ¥ 2025-12-09"><meta itemprop=description content="ğŸ“… Daily Report - 2025-12-09 ä»Šæ—¥ç­›é€‰å‡º 23 æ¡å†…å®¹ï¼Œæ¥è‡ª 1 ä¸ªæ¥æº"><meta itemprop=datePublished content="2025-12-09T00:00:00+00:00"><meta itemprop=dateModified content="2025-12-09T00:00:00+00:00"><meta itemprop=wordCount content="2087"><meta itemprop=keywords content="Research,Daily,Week502025"><meta name=twitter:card content="summary"><meta name=twitter:title content="ç§‘ç ”æ—¥æŠ¥ 2025-12-09"><meta name=twitter:description content="ğŸ“… Daily Report - 2025-12-09 ä»Šæ—¥ç­›é€‰å‡º 23 æ¡å†…å®¹ï¼Œæ¥è‡ª 1 ä¸ªæ¥æº"><link rel=preconnect href=https://fonts.gstatic.com crossorigin><link rel=dns-prefetch href=//fonts.googleapis.com><link rel=dns-prefetch href=//fonts.gstatic.com><link rel=stylesheet href="https://fonts.googleapis.com/css?family=Open+Sans:400,400i,700"><link rel=stylesheet href=../../../css/style.css><link rel=stylesheet href=../../../css/custom.css><link rel="shortcut icon" href=../../../favicon.ico></head><body class=body><div class="container container--outer"><header class=header><div class="container header__container"><div class=logo><a class=logo__link href=../../../ title=ç”Ÿä¿¡æ™®æ‹‰æ–¯ rel=home><div class="logo__item logo__text"><div class=logo__title>ç”Ÿä¿¡æ™®æ‹‰æ–¯</div><div class=logo__tagline>è¿‘åå¹´æœ€å€¼å¾—ä¸Šæ‰‹çš„ç”Ÿç‰©åŒ»å­¦ç”Ÿä¿¡ä»£ç </div></div></a></div><nav class=menu><button class=menu__btn aria-haspopup=true aria-expanded=false tabindex=0>
<span class=menu__btn-title tabindex=-1>Menu</span></button><ul class=menu__list><li class=menu__item><a class=menu__link href=../../../posts/><span class=menu__text>æ–‡ç« </span></a></li><li class=menu__item><a class=menu__link href=../../../tags/><span class=menu__text>æ ‡ç­¾</span></a></li><li class=menu__item><a class=menu__link href=../../../about/><span class=menu__text>å…³äº</span></a></li></ul></nav></div></header><div class="wrapper flex"><div class=primary><main class=main role=main><article class=post><header class=post__header><meta name=referrer content="never"><h1 class=post__title>ç§‘ç ”æ—¥æŠ¥ 2025-12-09</h1><div class="post__meta meta"><div class="meta__item-datetime meta__item"><svg class="meta__icon icon icon-time" width="16" height="14" viewBox="0 0 30 28"><path d="M15 0a14 14 0 110 28 1 1 0 010-28m0 3a3 3 0 100 22 3 3 0 000-22m1 4h-2v8.4l6.8 4.4L22 18l-6-3.8z"/></svg><time class=meta__text datetime=2025-12-09T00:00:00Z>2025-12-09</time></div><div class="meta__item-categories meta__item"><svg class="meta__icon icon icon-category" width="16" height="16" viewBox="0 0 16 16"><path d="m7 2 1 2h8v11H0V2z"/></svg><span class=meta__text><a class=meta__link href=../../../categories/dailyreport/ rel=category>DailyReport</a></span></div><div class="meta__item-author meta__item"><svg class="meta__icon icon icon-author" width="16" height="16" viewBox="0 0 16 16"><path d="M8 1c2 0 3.5 2 3.5 4.5S10 9 10 9c3 1 4 2 4 6H2c0-4 1-5 4-6 0 0-1.5-1-1.5-3.5S6 1 8 1"/></svg><span class=meta__text>Bloger</span></div></div></header><div class="post__toc toc"><div class=toc__title>Page content</div><div class=toc__menu><nav id=TableOfContents><ul><li><a href=#-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</a><ul><li><a href=#-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</a></li></ul></li><li><a href=#-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</a><ul><li></li></ul></li><li><a href=#-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</a></li><li><a href=#-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</a></li></ul></nav></div></div><div class="content post__content clearfix"><h1 id=-daily-report---2025-12-09>ğŸ“… Daily Report - 2025-12-09</h1><blockquote><p>ä»Šæ—¥ç­›é€‰å‡º <strong>23</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>1</strong> ä¸ªæ¥æº</p></blockquote><div class=powered-by-top>Powered by <a href=https://kyplus.de>ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href=https://claude.ai>Claude</a></div><hr><h2 id=-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2><h3 id=-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
é¦–æ¬¡åˆ©ç”¨ç©ºé—´è½¬å½•ç»„å­¦ç»“åˆæ·±åº¦å­¦ä¹ ï¼Œå®ç°å­˜æ¡£FFPEæ ·æœ¬çš„é«˜åˆ†è¾¨ç‡å•ç»†èƒç©ºé—´å‰–æï¼Œæ¨åŠ¨äº†å¯¹è‚¾ç—…ç­‰ç–¾ç—…æœºåˆ¶çš„æ·±å…¥ç†è§£ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>å…ç–«ç»†èƒåŠŸèƒ½è°ƒæ§ï¼š BACH2è°ƒæ§Tç»†èƒè°±ç³»å¢å¼ºCAR-Tç»†èƒåŠŸèƒ½ï¼ŒNFATä»‹å¯¼èƒ°è…ºç™Œç›¸å…³æˆçº¤ç»´ç»†èƒçš„ä¿ƒè‚¿ç˜¤ç‚ç—‡ã€‚</li><li>ç–¾ç—…æœºåˆ¶æ¢ç´¢ï¼š æ­ç¤ºçƒ­ä¼‘å…‹é€šè·¯å¯¹å™ªéŸ³æ€§å¬åŠ›æŸå¤±çš„ä¿æŠ¤ä½œç”¨ï¼ŒCRHç¥ç»å…ƒæ¿€æ´»ä¿ƒè¿›åŠ¨è„‰ç²¥æ ·ç¡¬åŒ–ã€‚</li><li>åŸºå› ç»„ä¸è¡¨è§‚é—ä¼ å­¦ï¼š æ¢ç´¢ERÎ±ç»“åˆåŠåŸºå› è¡¨è¾¾åœ¨å­å®«å†…è†œç™Œä¸­çš„è°ƒæ§æœºåˆ¶ï¼Œæ£€æµ‹äººç±»èƒšèƒæŸ“è‰²ä½“å¼‚å¸¸ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>é«˜åˆ†è¾¨ç‡ç©ºé—´è½¬å½•ç»„å­¦ï¼ˆVisium HDï¼‰ç»“åˆæ·±åº¦å­¦ä¹ å›¾åƒåˆ†å‰²ã€‚</li><li>å¤šç»„å­¦æŠ€æœ¯ï¼ˆATAC-seq, CRISPRScreen, Ribo-seq, Multiomeï¼‰ååŒåº”ç”¨ã€‚</li></ul><hr><h2 id=-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</h2><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§¬ æ•°æ®å‰æ²¿ (23æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å‰10æ¡>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4><p><strong>1.</strong> â­ <strong>GSE312646 TRC-051384æ¿€æ´»çƒ­ä¼‘å…‹é€šè·¯ä¿æŠ¤èºæ—‹ç¥ç»èŠ‚ç¥ç»å…ƒå…å—å™ªå£°å¼•èµ·çš„å¬åŠ›æŸå¤±[ç©ºé—´è½¬å½•ç»„å­¦]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šspatialã€spatial transcriptomicsã€transcriptomicsã€pathway</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Jeffrey N Savas ; Seby Edassery ; Miguel RamirezSeries Type : OtherOrganism : Mus musculusNoise-induced hearing loss (NIHL) is a major public health problem caused by damage to cochlear hair cells, synapses, and spiral ganglion neurons (SGNs). However, effective treatments are completely lacking. We investigated cellular stress responses induced by loud noise in a mouse model of cochlear synaptopathy and tested whether selective activation of the dominant pathway identified could confer protection. RNA sequencing and spatial transcriptomics revealed that noise exposure elicited a robust but transient upregulation of endoplasmic reticulum chaperones and proteasome subunits in SGNs and supporting cells. To target this response, we administered TRC051384, a small-molecule activator of the heat shock transcription factor Hsf1, prior to noise exposure. TRC051384 crossed the bloodâ€“labyrinth barrier and reached the cochlea, induced heat shock protein gene expression, and restored ubiquitinâ€“proteasome function in SGNs. Notably, TRC051384 treatment improved auditory brainstem response recovery, preserved Wave I amplitudes, and maintained ribbon synapse density. These findings establish proteotoxic stress in SGNs as a central driver of NIHL and identify HSF1 activation as a promising therapeutic strategy.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312646">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> <strong>GSE312570 çµé•¿ç±»è‚ é“èŒç¾¤è¯±å¯¼å°é¼ ç¥ç»å‘è‚²ä¸­å…·æœ‰è¿›åŒ–æ„ä¹‰çš„å˜åŒ–</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šgutã€regex:gut(-?microbiome)?</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Alex DeCasien ; Jacob Arnoff ; Elizabeth Mallot ; Sahana Kuthyar ; Sriram Chitta ; Brian Layden ; Maria Savo Sardaro ; Stanton Grey ; Lawrence Williams ; Emma Leichty ; Hyo Lee ; Won Lee ; James Curly ; Christopher Kuzawa ; Katherine AmatoSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusMultiple primate species, including humans, evolved brains that are exceptionally large relative to their body sizes. These large brains coevolved with metabolic adaptations that enhance cerebral energy supply, including increased circulating glucose levels. While the gut microbiota (GM) is known to influence host metabolism, its potential role in primate brain evolution remains unclear. To investigate this, we inoculated germ-free mice with the GMs of primate species selected to separate the effects of brain size (encephalization) from phylogenetic relatedness: humans (large-brained, Catarrhini), macaques (smaller-brained, Catarrhini), and squirrel monkeys (large-brained, Platyrrhini). We first show that differences in brain gene expression between mice inoculated with human versus macaque GMs resemble those observed between actual human and macaque brains. Comparing the effects of the different primate GMs on mouse brain gene expression further revealed that, despite greater evolutionary distance, the GMs from the two larger-brained species (humans and squirrel monkeys) similarly upregulated genes associated with energy production. Notably, human GMs specifically increased the expression of genes involved in oxidative phosphorylation, and these gene expression changes correlated with increased abundances of GM metabolic pathways related to glucose metabolism and gluconeogenesis. Human GMs also downregulated evolutionarily conserved genes implicated in neurodevelopmental disorders such as autism. Although these are findings based on a small sample of primate species and must be interpreted as preliminary, they suggest that species differences in GM composition can influence brain metabolism and raise the possibility that the GM could have played a supporting role in primate encephalization.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312570">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> <strong>GSE312384 BACH2 è°ƒæ§ T ç»†èƒè°±ç³»çŠ¶æ€ä»¥å¢å¼º CAR T ç»†èƒåŠŸèƒ½ [ATAC-seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šT cellã€ATAC-seq</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Tien-Ching Chang ; John M Warrington ; Nathan A SinghSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensNearly all chimeric antigen receptors (CARs) signal in the absence of antigen, referred to as â€œtonic signalingâ€. Tonic signaling of CARs containing the CD28 costimulatory domain has been shown to driveT cell exhaustion; in contrast, we found that tonic signaling of 41BB-containing CARs enhances T cell function. Using a panel of CARs targeting CD22, we identified that tonic 41BB signaling activatesBACH2, a transcriptional regulator that directs stem and memory programs. Overexpression of BACH2 prevented tonic CD28-driven exhaustion but locked CAR T cells in quiescent states. To overcome this, we linked BACH2 to a degradation domain and found that tuning BACH2 expression enhanced long-term efficacy of exhaustion-prone CAR T cells targeting liquid and solid tumors. Through interrogation of CAR products, we also found an association between BACH2 activity and clinical outcomes in patients with leukemia. These data identify a central role for BACH2 in regulating CAR T cell efficacy.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312384">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>4.</strong> <strong>GSE312224 å°é¼ è€³èœ—è¡€ç®¡çº¹å†…çš®ç»†èƒå’Œå‘¨ç»†èƒç¾¤çš„å•ç»†èƒRNAæµ‹åº</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šRNA-seqã€single-cell</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Zhiqiang Hou ; Yunpei Zhang ; Jinhui Zhang ; Pingting Wang ; Xiaorui ShiSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusThe cochlear stria vascularis (SV) maintains the endocochlear potential and relies on specialized vascular endothelial cells and pericytes. To characterize the transcriptional profiles of these vascular populations at single-cell resolution, we performed single-cell RNA sequencing (scRNA-seq) on SV tissue from reporter mice. SV was microdissected from temporal bones of 1â€“3 month-old Tie2-GFP (endothelial reporter) and NG2-DsRed (pericyte reporter) mice, enzymatically dissociated to obtain single-cell suspensions, and, when applicable, subjected to FACS enrichment for Tie2-GFPâ€“positive endothelial cells or NG2-DsRedâ€“positive pericytes. Viable cells were loaded onto the 10x Genomics Chromium platform for single-cell capture and 3â€² barcoded library preparation. This dataset contains two independent batches corresponding to SV endothelial cellâ€“enriched and pericyte-enriched preparations and enables analysis of vascular heterogeneity within the mouse stria vascularis.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312224">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>5.</strong> <strong>GSE300895 é«˜åˆ†è¾¨ç‡ç©ºé—´è½¬å½•ç»„å­¦ç»“åˆåŸºäºæ·±åº¦å­¦ä¹ çš„å›¾åƒåˆ†å‰²æŠ€æœ¯ï¼Œå®ç°äº†å¯¹ç‰¹å‘æ€§è‚¾ç—…ç»¼åˆå¾æ‚£è€…çš„å­˜æ¡£FFPEè‚¾è„ç»„ç»‡è¿›è¡Œå•ç»†èƒç©ºé—´åˆ†æã€‚</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsingle-cellã€spatial</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Simen F Pettersen ; Eleni Skandalou ; Jessica Furriol ; Tarig Osman ; Hans-Peter Marti ; Ã˜ystein S EikremSeries Type : OtherOrganism : Homo sapiensWe have perfomed Visium HD spatial transcriptomics on archival FFPE kidney biopsies from patients with different manifistations of nephrotic syndrome, i.e., steriod sensitive, frequent relapsing and/or steroid dependent, and focal segmental glomerulosclerosis. Using a pre-trained deep learning model from StarDist to segment nuclei, we reconstructed single-nucleus level spatial trancriptomic datasets through custom binning of subcellular capture areas. We integrated the datasets from the different patients and indentified conserved cell types. Moreover, we identified patient specific transcriptomic differences in the podocyte cell population. This article demonstrates the usefullness of this approach to future studies of pathophysilogical mechanisms in idiopathic nephrotic syndrome.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300895">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>6.</strong> <strong>GSE292096 NFATä»‹å¯¼èƒ°è…ºå¯¼ç®¡è…ºç™Œä¸­ç™Œç›¸å…³æˆçº¤ç»´ç»†èƒçš„ä¿ƒè‚¿ç˜¤ç‚ç—‡[å°é¼ VIVIT]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€inflammation</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Chuner Guo ; Michelle F Griffin ; Annah G Morgan ; Michael T Longaker ; Jeffrey A NortonSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusPancreatic ductal adenocarcinoma (PDAC) is characterized by a dense stroma, low immunogenicity, and resistance to therapy. Cancer-associated fibroblasts (CAFs) are key stromal cells within the tumor microenvironment (TME) that drive tumor progression. Interleukin-1 (IL-1) promotes fibrosis, pathogenic inflammation, and poor prognosis in PDAC. Using a novel single-cell multiomic approach, we investigate the IL-1 signaling axis in human and mouse models of PDAC, identifying nuclear factor of activated T cells (NFAT) transcription factors as key mediators. IL1R1+ CAFs activate an inflammatory phenotype associated with elevated NFAT motif activity and gene expression. In vivo, NFAT inhibition in a mouse model of PDAC significantly reduces tumor weight and fibrosis, supporting its pro-tumorigenic role. Our findings suggest that NFAT mediates IL-1-induced inflammation in PDAC, highlighting its potential as a therapeutic target. This study demonstrates the power of multiomic analyses to uncover therapeutic targets within the complex tumor microenvironment.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE292096">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>7.</strong> <strong>GSE292095 NFAT ä»‹å¯¼èƒ°è…ºå¯¼ç®¡è…ºç™Œä¸­ç™Œç›¸å…³æˆçº¤ç»´ç»†èƒçš„ä¿ƒè‚¿ç˜¤ç‚ç—‡ [äººç±»å¤šç»„å­¦]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€inflammation</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Chuner Guo ; Michelle F Griffin ; Annah G Morgan ; Michael T Longaker ; Jeffrey A NortonSeries Type : Expression profiling by high throughput sequencing ; Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensPancreatic ductal adenocarcinoma (PDAC) is characterized by a dense stroma, low immunogenicity, and resistance to therapy. Cancer-associated fibroblasts (CAFs) are key stromal cells within the tumor microenvironment (TME) that drive tumor progression. Interleukin-1 (IL-1) promotes fibrosis, pathogenic inflammation, and poor prognosis in PDAC. Using a novel single-cell multiomic approach, we investigate the IL-1 signaling axis in human and mouse models of PDAC, identifying nuclear factor of activated T cells (NFAT) transcription factors as key mediators. IL1R1+ CAFs activate an inflammatory phenotype associated with elevated NFAT motif activity and gene expression. In vivo, NFAT inhibition in a mouse model of PDAC significantly reduces tumor weight and fibrosis, supporting its pro-tumorigenic role. Our findings suggest that NFAT mediates IL-1-induced inflammation in PDAC, highlighting its potential as a therapeutic target. This study demonstrates the power of multiomic analyses to uncover therapeutic targets within the complex tumor microenvironment.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE292095">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>8.</strong> <strong>GSE292094 NFATä»‹å¯¼èƒ°è…ºå¯¼ç®¡è…ºç™Œä¸­ç™Œç›¸å…³æˆçº¤ç»´ç»†èƒçš„ä¿ƒè‚¿ç˜¤ç‚ç—‡[å°é¼ å¤šç»„å­¦]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€inflammation</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Chuner Guo ; Michelle F Griffin ; Annah G Morgan ; Michael T Longaker ; Jeffrey A NortonSeries Type : Expression profiling by high throughput sequencing ; Genome binding/occupancy profiling by high throughput sequencingOrganism : Mus musculusPancreatic ductal adenocarcinoma (PDAC) is characterized by a dense stroma, low immunogenicity, and resistance to therapy. Cancer-associated fibroblasts (CAFs) are key stromal cells within the tumor microenvironment (TME) that drive tumor progression. Interleukin-1 (IL-1) promotes fibrosis, pathogenic inflammation, and poor prognosis in PDAC. Using a novel single-cell multiomic approach, we investigate the IL-1 signaling axis in human and mouse models of PDAC, identifying nuclear factor of activated T cells (NFAT) transcription factors as key mediators. IL1R1+ CAFs activate an inflammatory phenotype associated with elevated NFAT motif activity and gene expression. In vivo, NFAT inhibition in a mouse model of PDAC significantly reduces tumor weight and fibrosis, supporting its pro-tumorigenic role. Our findings suggest that NFAT mediates IL-1-induced inflammation in PDAC, highlighting its potential as a therapeutic target. This study demonstrates the power of multiomic analyses to uncover therapeutic targets within the complex tumor microenvironment.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE292094">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>9.</strong> <strong>GSE292093 NFATä»‹å¯¼èƒ°è…ºå¯¼ç®¡è…ºç™Œä¸­ç™Œç›¸å…³æˆçº¤ç»´ç»†èƒçš„ä¿ƒè‚¿ç˜¤ç‚ç—‡[å°é¼ æ¨¡å‹]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€inflammation</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Chuner Guo ; Michelle F Griffin ; Annah G Morgan ; Michael T Longaker ; Jeffrey A NortonSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusPancreatic ductal adenocarcinoma (PDAC) is characterized by a dense stroma, low immunogenicity, and resistance to therapy. Cancer-associated fibroblasts (CAFs) are key stromal cells within the tumor microenvironment (TME) that drive tumor progression. Interleukin-1 (IL-1) promotes fibrosis, pathogenic inflammation, and poor prognosis in PDAC. Using a novel single-cell multiomic approach, we investigate the IL-1 signaling axis in human and mouse models of PDAC, identifying nuclear factor of activated T cells (NFAT) transcription factors as key mediators. IL1R1+ CAFs activate an inflammatory phenotype associated with elevated NFAT motif activity and gene expression. In vivo, NFAT inhibition in a mouse model of PDAC significantly reduces tumor weight and fibrosis, supporting its pro-tumorigenic role. Our findings suggest that NFAT mediates IL-1-induced inflammation in PDAC, highlighting its potential as a therapeutic target. This study demonstrates the power of multiomic analyses to uncover therapeutic targets within the complex tumor microenvironment.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE292093">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>10.</strong> <strong>GSE275826 å¹´è½»å’Œè¡°è€çœŸçš®å·¨å™¬ç»†èƒçš„å•ç»†èƒè½¬å½•ç»„æ¯”è¾ƒ</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsingle-cell</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Yu-Tung Li ; Saki IshinoSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusPreviously, in a meta-analysis of public single-cell transcriptomes profiling various healthy and disease tissues, we demonstrated that macrophage heterogeneity in skin, as well as in other mouse tissues, could be described into 5 distinct identities (S1-5) with a defined transcriptomic fingerprint, regardless of tissue origins. We established a general identity scheme for tissue macrophages, MIKA (Macrophage Identity Kinetics Archive) as an alternative to the conventional M1/M2 scheme which shows limitations in annotating in vivo tissue macrophages. (PMID: 39720957) MIKA was recently updated to finetune identity definition, and to include more tissues and pathophysiological conditions. (PMID: 41342690) Under the current MIKA framework, tissue macrophages are classified to 6 core identities (S1-S6, common to various tissues) and/or tissue-specific macrophages. This dataset is a part of the raw data sources of the latest version of MIKA profiling single-cell transcriptomes of F4/80+MHCII-hi macrophages FACS-isolated from dorsal skin of young (9 week-old) and old (108 week-old) C57BL/6 male mice.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE275826">æŸ¥çœ‹åŸæ–‡</a></li></ul><blockquote><p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 13 æ¡å†…å®¹ï¼Œè¯¦è§ <a href=#%E6%9B%B4%E5%A4%9A-%E6%95%B0%E6%8D%AE%E5%89%8D%E6%B2%BF>æ–‡æœ«</a></p></blockquote></div></details><h2 id=-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2><table><thead><tr><th>å…³é”®è¯</th><th>å‡ºç°æ¬¡æ•°</th></tr></thead><tbody><tr><td>cancer</td><td>6</td></tr><tr><td>inflammation</td><td>4</td></tr><tr><td>single-cell</td><td>3</td></tr><tr><td>T cell</td><td>3</td></tr><tr><td>immune</td><td>3</td></tr><tr><td>spatial</td><td>2</td></tr><tr><td>transcriptomics</td><td>2</td></tr><tr><td>spatial transcriptomics</td><td>1</td></tr><tr><td>pathway</td><td>1</td></tr><tr><td>gut</td><td>1</td></tr><tr><td>regex:gut(-?microbiome)?</td><td>1</td></tr><tr><td>ATAC-seq</td><td>1</td></tr><tr><td>transcriptome</td><td>1</td></tr><tr><td>RNA-seq</td><td>1</td></tr><tr><td>tumor</td><td>1</td></tr><tr><td>Neuronal</td><td>1</td></tr><tr><td>genome</td><td>1</td></tr><tr><td>methylation</td><td>1</td></tr></tbody></table><hr><h2 id=-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</h2><details><summary><a name=æ›´å¤š-æ•°æ®å‰æ²¿></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (13æ¡)</summary><div class=details-content markdown=1><ul><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312389">GSE312389 åˆ©ç”¨é«˜é€‰æ‹©æ€§ T ç»†èƒå—ä½“é¶å‘ç”Ÿç‰©åˆ¶å‰‚é˜æ˜å…±åˆºæ¿€ä¿¡å·åœ¨äººç±»ç—…æ¯’ç‰¹å¼‚æ€§è®°å¿† CD8+ T ç»†èƒæ´»åŒ–å’Œæ‰©å¢ä¸­çš„ä½œç”¨</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312367">GSE312367 BACH2 è°ƒæ§ T ç»†èƒè°±ç³»çŠ¶æ€ä»¥å¢å¼º CAR T ç»†èƒåŠŸèƒ½ [Cut & Run]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312344">GSE312344 äº§ç§‘æŠ—ç£·è„‚ç»¼åˆå¾çš„å…¨è½¬å½•ç»„åˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312323">GSE312323 é‰´å®šå¯¹é›Œæ¿€ç´ å—ä½“Î±ç»“åˆåŠå…¶å¯¹å­å®«å†…è†œç™ŒåŸºå› è¡¨è¾¾çš„å½±å“å…·æœ‰ç‹¬ç‰¹å½±å“çš„åŸºå› ç»„ç‰¹å¾ [SOX17_ChIPseq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312322">GSE312322 é‰´å®šå¯¹é›Œæ¿€ç´ å—ä½“Î±ç»“åˆåŠå…¶å¯¹å­å®«å†…è†œç™ŒåŸºå› è¡¨è¾¾çš„å½±å“å…·æœ‰ç‹¬ç‰¹å½±å“çš„åŸºå› ç»„ç‰¹å¾ [CRISPRScreen]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312030">GSE312030 HRAS å’Œ MEK è”åˆæŠ‘åˆ¶å¯è¯±å¯¼ HRAS çªå˜å‹æ¨ªçº¹è‚Œè‚‰ç˜¤çš„è‚¿ç˜¤æ¶ˆé€€å¹¶æ¢å¤å…¶è‚Œæºæ€§åˆ†åŒ–</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312004">GSE312004 ä¸‹ä¸˜è„‘CRHç¥ç»å…ƒæ¿€æ´»è§¦å‘è„¾ç»†èƒå¢æ®–å¹¶ä¿ƒè¿›åŠ¨è„‰ç²¥æ ·ç¡¬åŒ–</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311964">GSE311964 Biop-C èƒ½å¤Ÿæ£€æµ‹æ¤å…¥å‰äººç±»èƒšèƒä¸­å¹³è¡¡å’Œéå¹³è¡¡é‡æ’çš„å…¨åŸºå› ç»„èŒƒå›´</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288397">GSE288397 æ•´åˆæœºå™¨å­¦ä¹ å’Œè½¬å½•ç»„å­¦ä»¥æé«˜é…µæ¯ä¸­Î²-èƒ¡èåœç´ çš„äº§é‡</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE286715">GSE286715 t6A tRNA ä¿®é¥°å®šä¹‰äº† RIG-I ä»‹å¯¼çš„æŠ—è‚¿ç˜¤å…ç–«ååº” [RNA-seq2]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE286709">GSE286709 t6A tRNA ä¿®é¥°å®šä¹‰äº† RIG-I ä»‹å¯¼çš„æŠ—è‚¿ç˜¤å…ç–«ååº” [RNA-seq1]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE286704">GSE286704 t6A tRNAä¿®é¥°å®šä¹‰äº†RIG-Iä»‹å¯¼çš„æŠ—è‚¿ç˜¤[Ribo-seq]å…ç–«ååº”</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283783">GSE283783 ä¸¥é‡é˜»å¡æ€§ç¡çœ å‘¼å¸æš‚åœæˆå¹´æ‚£è€…åœ¨ CPAP æ²»ç–—å‰åçš„ç”²åŸºåŒ–åˆ†æã€‚</a></li></ul></div></details><hr><p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2025-12-08 21:34</em><br><em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p></div><footer class=post__footer><div class="post__tags tags clearfix"><svg class="tags__badge icon icon-tag" width="16" height="16" viewBox="0 0 32 32"><path d="M4 0h8s2 0 4 2l15 15s2 2 0 4L21 31s-2 2-4 0L2 16s-2-2-2-4V3s0-3 4-3m3 10a3 3 0 000-6 3 3 0 000 6"/></svg><ul class=tags__list><li class=tags__item><a class="tags__link btn" href=../../../tags/research/ rel=tag>Research</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/daily/ rel=tag>Daily</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/week502025/ rel=tag>Week502025</a></li></ul></div></footer></article></main><div class="authorbox clearfix"><div class=authorbox__header><span class=authorbox__name>About Bloger</span></div></div><nav class="pager flex"><div class="pager__item pager__item--prev"><a class=pager__link href=../../../posts/dailyreports/2025-12-08/ rel=prev><span class=pager__subtitle>Â«&#8201;Previous</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2025-12-08</p></a></div><div class="pager__item pager__item--next"><a class=pager__link href=../../../posts/dailyreports/2025-12-10/ rel=next><span class=pager__subtitle>Next&#8201;Â»</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2025-12-10</p></a></div></nav><section class=comments><div id=disqus_thread></div><script>window.disqus_config=function(){},function(){if(["localhost","127.0.0.1"].indexOf(window.location.hostname)!=-1){document.getElementById("disqus_thread").innerHTML="Disqus comments not available by default when the website is previewed locally.";return}var t=document,e=t.createElement("script");e.async=!0,e.src="//kkitown.disqus.com/embed.js",e.setAttribute("data-timestamp",+new Date),(t.head||t.body).appendChild(e)}()</script><noscript>Please enable JavaScript to view the <a href=https://disqus.com/?ref_noscript>comments powered by Disqus.</a></noscript><a href=https://disqus.com class=dsq-brlink>comments powered by <span class=logo-disqus>Disqus</span></a></section></div><aside class=sidebar><div class="widget-search widget"><form class=widget-search__form role=search method=get action=https://google.com/search><input class=widget-search__field type=search placeholder=Searchâ€¦ name=q aria-label=Searchâ€¦>
<input class=widget-search__submit type=submit value=Search>
<input type=hidden name=sitesearch value=https://ixxmu.github.io/></form></div><div class="widget-recent widget"><h4 class=widget__title>Recent Posts</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-02/>ç§‘ç ”æ—¥æŠ¥ 2026-02-02</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-01/>ç§‘ç ”æ—¥æŠ¥ 2026-02-01</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-01-31/>ç§‘ç ”æ—¥æŠ¥ 2026-01-31</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-01-30/>ç§‘ç ”æ—¥æŠ¥ 2026-01-30</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-01-29/>ç§‘ç ”æ—¥æŠ¥ 2026-01-29</a></li></ul></div></div><div class="widget-categories widget"><h4 class=widget__title>Categories</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../categories/dailyreport/>DailyReport</a></li><li class=widget__item><a class=widget__link href=../../../categories/learnr/>LearnR</a></li></ul></div></div><div class="widget-taglist widget"><h4 class=widget__title>Tags</h4><div class=widget__content><a class="widget-taglist__link widget__link btn" href=../../../tags/daily/ title=Daily>Daily (96)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/research/ title=Research>Research (96)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week022026/ title=Week022026>Week022026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week032026/ title=Week032026>Week032026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week042026/ title=Week042026>Week042026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week052026/ title=Week052026>Week052026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week452025/ title=Week452025>Week452025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week462025/ title=Week462025>Week462025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week472025/ title=Week472025>Week472025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week482025/ title=Week482025>Week482025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week492025/ title=Week492025>Week492025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week502025/ title=Week502025>Week502025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week512025/ title=Week512025>Week512025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week522025/ title=Week522025>Week522025 (7)</a></div><a href=../../../tags/></a></div><div class="widget-social widget"><h4 class="widget-social__title widget__title">Social</h4><div class="widget-social__content widget__content"><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Facebook rel="noopener noreferrer" href=https://facebook.com/username target=_blank><svg class="widget-social__link-icon icon icon-facebook" width="24" height="24" viewBox="0 0 352 352"><path d="m0 32v288c0 17.5 14.5 32 32 32h288c17.5.0 32-14.5 32-32V32c0-17.5-14.5-32-32-32H32C14.5.0.0 14.5.0 32zm320 0v288h-83V212h41.5l6-48H237v-31c0-14 3.5-23.5 23.5-23.5h26V66c-4.4-.6-19.8-1.5-37.5-1.5-36.9.0-62 22.2-62 63.5v36h-42v48h42v108H32V32z"/></svg>
<span>Facebook</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Twitter rel="noopener noreferrer" href=https://twitter.com/username target=_blank><svg class="widget-social__link-icon icon icon-twitter" width="24" height="24" viewBox="0 0 384 312"><path d="m384 36.9c-14.1 6.3-29.3 10.5-45.2 12.4 16.3-9.7 28.8-25.2 34.6-43.6-15.2 9-32.1 15.6-50 19.1-14.4-15.2-34.9-24.8-57.5-24.8-43.5.0-78.8 35.3-78.8 78.8.0 6.2.7 12.2 2 17.9-65.5-3.3-123.5-34.6-162.4-82.3C20 26 16.1 39.6 16.1 54c0 27.3 13.9 51.4 35 65.6-12.9-.4-25.1-4-35.7-9.9v1c0 38.2 27.2 70 63.2 77.2-6.6 1.8-13.6 2.8-20.8 2.8-5.1.0-10-.5-14.8-1.4 10 31.3 39.1 54.1 73.6 54.7-27 21.1-60.9 33.7-97.8 33.7-6.4.0-12.6-.4-18.8-1.1C34.9 299 76.3 312 120.8 312c144.9.0 224.1-120 224.1-224.1.0-3.4-.1-6.8-.2-10.2 15.4-11.1 28.7-25 39.3-40.8z"/></svg>
<span>Twitter</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Instagram rel="noopener noreferrer" href=https://www.instagram.com/username target=_blank><svg class="widget-social__link-icon icon icon-instagram" width="24" height="24" viewBox="0 0 256 256"><circle cx="193" cy="59" r="15"/><path fill-rule="evenodd" d="M101 0h54c41 0 58.4 3.9 74.5 17C256.2 37.5 256 74.8 256 97.7v60c0 26.7.0 60.4-26.5 81.4-16 13.4-33.5 16.9-74.5 16.9h-54c-41 0-57.5-3.5-74.5-16.9C1 218.9.5 186.3.1 160.5L0 155V97.7c0-23-.2-60.2 26.5-80.7C45 2 60 0 101 0zm4.9 23h44.3c45.8.0 58.3 3.5 70.3 17.5 11.8 13.2 12 30.1 12.5 62.9V156c.2 20.8.3 45.8-12.5 59.5-12 14-24.5 17.5-70.3 17.5h-44.3c-45.9.0-57.3-3.5-70.4-17.5-12.2-13-12.3-36.5-12.4-56.7v-55.6c.4-32.6.7-49.6 12.4-62.7C48 26.5 60 23 105.9 23zm19.6 144.5a42 42 0 100-84 42 42 0 000 84zm0 22.5a64.5 64.5.0 100-129 64.5 64.5.0 000 129z"/></svg>
<span>Instagram</span></a></div></div></div></aside></div><footer class=footer><div class="container footer__container flex"><div class=footer__copyright>&copy; 2026 ç”Ÿä¿¡æ™®æ‹‰æ–¯.
<span class=footer__copyright-credits>Generated with <a href=https://gohugo.io/ rel="nofollow noopener" target=_blank>Hugo</a> and <a href=https://github.com/Vimux/Mainroad/ rel="nofollow noopener" target=_blank>Mainroad</a> theme.</span></div></div></footer></div><script async defer src=../../../js/menu.js></script><script src=../../../js/custom.js></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.6/MathJax.js?config=TeX-AMS-MML_HTMLorMML" async></script></body></html>